Ginger E. Nicol
Child and Adolescent Psychiatry
4444 Forest Park Ave Ste 2600
Saint Louis,, MO 63108
Saint Louis,, MO 63108
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History.
Journal: The Journal of clinical psychiatry
Published: June 12, 2026
Correction: Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 19, 2026
Trends in Hallucinogen-Related Emergency Department and Hospital Admissions, 2016 to 2023.
Journal: JAMA network open
Published: November 13, 2025
Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: August 01, 2025
Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.
Journal: Scientific data
Published: June 18, 2025
Stimulant medications affect arousal and reward, not attention.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Stimulant medications affect arousal and reward, not attention networks.
Journal: Cell
Published: May 29, 2025
Optimizing the Work of Learning for Flourishing: A Randomized Pilot Study of a Digital CBT-Based Intervention in Medical Students.
Journal: Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
Published: May 14, 2025
Risk Factors for Falls in Older Depressed Adults Treated with Bupropion: An Analysis of the OPTIMUM Randomized Clinical Trial.
Journal: Journal of general internal medicine
Published: April 03, 2025
High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment.
Journal: Clinical and translational science
Published: March 26, 2025
Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders.
Journal: F1000Research
Published: February 03, 2025
Last Updated: 09/26/2026